Halma to acquire Dreampath Diagnostics for up to €275M (3906.0000p, 0)
Goldman Sachs monthly changes to European Conviction List - Directors' Cut
StreetAccount Summary - Trading higher/lower: EU mid-morning
Halma upgraded to outperform from neutral at BNP Paribas Exane (3898.0000p, 0)
Halma upgraded to buy from neutral at Citi (pre-UK open) (3928.0000p, 0)
Powered by FactSet Research Systems Inc.